T hree m ethod s of m easurin g t h e epidermolytic toxin of Staphy lococc us aureus-bioassay in newborn m ice, radia l immunodiffusion , a nd ra dioimmun oa ssay-were compa red for re producibility, s pec ificity, a nd sens it ivity. The bioassay is highly s pecifi c a nd rem a ins the only functiona l assay. It is reproducible only if newb orn mice of t he sa m e age a re used . The t ime req uired fo r epidermolysis fo llows a d ose-response relation ship only if con cen t rat ions of t oxin la rge en ough to ca use peeling in 90 min or less a re u sed . This limits the sensit ivity of t h e bioassay to a bout 5 J. L g per m\.
In 1970 M elish a nd G lasgow proposed t ha t a n epidermolytic toxin was responsible for t he sta phylococcal sca lded-skin syndrom e [1] . S ince t hen t his toxin , (called by va ri ous a u t hors epidermolys in , epidermolyti c toxin , exfoliatin , ex folia ting toxin ), has b een puri fied a nd p a rt ia lly ch a racteri zed by severa l investigators [2] [3] [4] [5] [6] . Acc urate m easurem en t of toxin is necessary to furt h er ch a racteri ze it a nd to delineate its ro le in Stap hy lococc us aureusassociated sca lded -skin syndrome.
M easurem ent of epidermolys in h as b een limi ted to a fun ctiona l bioassay in n ewborn mice. In our labo ratori es, bioassay resul ts we re found to b e q ui te va ri a ble when t he sa m e amo un t of toxi n was inj ected into severa l m ice from di ffere n t li tte rs. Because of t hi s observation , t he fo llowing study was underta ken to exa mine t h e fac tors producing variab ility in b ioassay resul ts . W e have a lso d eve l- Dr. Baker is the recipient of an Individual Research Fellowship 5 F22 AM 00900 and the J oseph Ga rdner Hopkins P rize presented at t he Society fo r Investigative Dermatology meeting, Atlantic City, N. J. , May 3, 1975. A preliminary report of these studies has bee n pub- Abb reviations: ABC-33: antige n-bind ing capacity ca lculated from the reciprocal of the serum dilu tion which precipitates 33 % of the antigen add ed BS A: bov ine se ru m albumin op ed other m ore sensit ive a nd re producibl e ways to m easure t h e epidermolytic toxin , ra dia l immunodiffusion , a nd ra dioimmunoassay.
MATERIALS AND METHODS
Epide rmolytic to xin was obta ined and purified as previously desc ribed l6 ] from Strain EV , a phage group II, ty pe 55/71, coagulase-posit ive S . aureus, isolated from a case of sta phylococca l scalded-skin sy ndrome. An tiserum to epiderm olysin was produced in rabbits as previo usly desc ri bed [6 j.
Bioassay
Newborn Webste r/Sw iss mice (Simo nso n Laboratori es, Gi lroy , Calif.) of known age (1 to 5 days) we re injected subcutaneo usly, in duplicate, in to the nape of the neck. We used 25-gauge needles, and 0.02-ml volumes of materi al were assayed for epiderm olytic tox in activity. The time required for production of a locali zed Nikolsky sign in the skin ove rlyi ng the site of injection was recorded as t he end poin t.
Radia l Immunodiffu sion
Rad ial immunodiffusion in aga r was carri ed out according to the method of Mancini et al [7] . In brief, a 1.5% aga r ge l plate (lonagar No.2, Difco , Detroit, Mich.) was prepared with 7.5 % rab bi t ant iserum to epidermolys in incorporated into the aga r. Circul ar wells were cut into t he aga r to allow introdu ction of 7-/l1 amoun ts of t he material to be assayed fo r epidermolys in . Radi al diffusion took place over a 7-to 10-day peri od at roo m temperature in humidity chambers. The di a meters of t he circ ul ar precipi t in bands that form ed were measured using a mi croscope oc ul ar eq uipped with a micrometer, and t he areas of the circles were calcul ated. Known a moun ts of epide rm olysi n we re introduced in to wells in t he sa me aga r ge l plate in whi ch unknowns were mea-
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s ured , a llowi ng a stand a rd cu rve to be pre pared for each assay run .
Radiolab eling of Epiderm olysin
Purifi ed epid ermolysin was radi oiodin ated wi t h I" iodin e (1 mCi/50 Ill , New England N ucl ea r, Boston , Mass.) and 50 III of chloramine T (1 m g/ ml) were add ed to purified epidermolysin (1200 Il g in 0.5 mI). Fifty III of sodi um metabisulfi te (1 mg/ ml) we re added to termin ate th e reaction . Bovine se rum a lbumin (BSA) (Sc hwa rz/ Mann , Ora nge burg, N .Y.), 0 .2% in sa line, was add ed as carr ie r. Free "'I was se parated from radiola beled epiderrnolys in by extensive di a lysis and passage over a Sephad ex G-50 column [8 1.
Saturated ammonium sulfate prec ipitation was in vest igated as a means of se parat in g free from a nt ibodybound epiderm olysin [9 J. Radiolabe led epidermolys in was in cub ated ove rni ght at 4°C. wit h phos phate-buffered sa line, ra bbit serum , human serum , or rab bit antiserum to epiderm olys in . Cold sat urated a mmonium sulfa te was then added in amounts sufficient to obtain final concent r ations of ammonium sulfate from 20 to 90 %. The precipitate whi ch form ed was ce ntrifuged, se parated from the supern atant, and counted in a we ll-type ga mma co un ter.
Chara cterization of the Rabbit Antiserum Used in the Radioim munoassay
Ra bbit antise rum to epiderm olysin was tested for its abil ity to bi nd rad iolabe led epiderm olysi n as fo ll ows: 0.5 m! of doubling di lu tions of anti-epidermolys in was incubated ove rni ght at 4°C. with constant amou nts of (I2>IJepidermolysin ( 100 ng in 0.5 mI) . Followin g incub ation, 1.0 ml of saturated ammonium sulfate was added. Precipita tes were cent rifuged at 4°C at 3000 g for 20 min , washed with 50% sat urated ammon ium s ulfate, recent ri fuged , a nd radioactivity in precipitates was co un ted in a well-type ga mma coun te r.
Assay System
T o assay unknown samples for e piderm olys in the fo llowi ng syste m was used: 0.5 ml of' rabbit anti-epidermolysin (1 :750) was added to 0.5 ml of [ 1 25 1 ]epiderm olysi n a nd 0.5 ml of varyin g dilut ions of sa mple to be assayed . Followin g incubation overni ght at 4°C, 1.5 ml of saturated a mmonium sulfate was added to effect precipitation of ant ibody-bound epiderm olysin. P recipi tates were centrifuged, was hed wit h 50% saturated a mm onium sul fate , recentrifuged , and radioactivity was determined . A standa rd curve was co nstructed with kn own q ua nti t ies of epiderm olysi n, measured by the method of Lowry et al (1 0 I with BSA as standard .
To determine whether other staphylococca l productsa -toxin, enterotoxin A, or enterotoxin B-could inhibit binding of [ 125 1 Jepidermolysin to rabbit anti-epidermolys in , [ 125 1 Jepidermolysin (100 ng in 0.5 ml ), rabbit anti-epidermolys in (1:750, 0 .5 mI l. and a mounts of a tox in , ente rotoxin A, or enterotoxin B from 0.5 to 100 Il g were in cubated together overni ght at 4°C. Saturated ammonium sul fate precipi ta tion , was hi ng, a nd ga mma count ing of precipitates were carri ed out as desc ribed .
RESULTS

Bioassay of Epidermolysin
The results of bioassay of a sin gle batch of toxin in mice of varying age are given in Fi gure 1. The end point of t he assay, loosening of t he epiderm is FIG. 1. Dose-response curve to highly purified epiderm olysin injected intracutaneously in mice of varying ages. The time required for production of a locali zed Nikolsky sign in skin ove rlying t he injection site was recorded as t he end poin t.
overl yi ng t he inj ection site in response to rubbing with a fin ge r (N ikolsky sign) , was clear-cut a nd could be measured accurate ly wi t hin a 2-to 5-min in terva l. There was close agreement between duplicate an ima ls.
The relationship between t he amount of epid ermolysin injected (dose) and t he time required for epidermolysis to develop (response) was linea r only if the response occurred in less t han 60 to 90 min . The results becam e erratic and non linear thereafter. As shown in Figure 1 , t he dose-response varied with t he age of t he mice inj ected ; t he assay was more sensitive in mice less t ha n 24 hr old .
To exclude t he possibili ty that deterioration of the toxin was responsible for t he delayed responses observed in older animals, experiments were repeated in 1-day-old mice. The resul ts coincided with the first determination, confirming that the toxin was stable. The minimum time required for epidermolysis was about 15 min. This was presumably due to the t ime required for passive diffusion from t he int radermal injection site to the overlying epid ermis. Apparently, systemic adsorpt ion also takes place, since animals which received higher doses would d evelop a positive Nikolsky sign at any skin site several hours after the initial injection .
Radial Immunodiffusion Assay (Mancini) fo r Epidermolysin
Single ra dial diffusion of a nti gen into agar containing a nt ibody to epidermolysin prov ided a reproducibl e, convenien t assay (Fig. 2) . The single, sharp rings of precipi tation developed fully in 7 to 10 days and were suitab le for measurement of toxin concen trations from 5 to 75 }. Lg per ml. (Fig. 5 left panel) . Using t he logit method fo r linea ri zation of data [11] , the graph in Figure 5 right panel was ob tained. Using t his assay we are a ble to m easure epidermolysin in con- Inset shows typical precipitin rin gs that develop 7 to 10 days after 7-1-' 1 sa mple is in trod uced in to wells cut in agar co ntain ing 7. 5% antibody.
Radioimmunoa.ssay (Fa rr) for Epidermolysin
[ ' 25 I]epidermolysin by bioassay was t he sa me as t hat of unlabeled toxin, abo ut 5 Ilg/m l. The labe l was indeed bound to t he toxin, s ince radioactivity and toxin comigrated in di sc gel electro phores is and t he precipitin rin gs which formed in Mancini radial diffusion pl ates conta ined t he ra dioactivity. The specific activity of t he [ ' 25 I]epidermolysin was 0.Q78 Ci/gm.
The solubility of t he toxin in ammoniu m s ulfate is shown in Figure 3 . With a 50 % saturated solu t ion of a mmonium s ulfate, when [ ' 25 I]epidermolysin was in cubated with immune rab bit serum (1:100), 80% of t he rad ioactivity added was precipitated ; whereas , wh en [ ' 25 I]epiderm olysin was inc ubated with selected human sera (1: 5), norm a l rabb it serum (1: 5), or phosphate-buffered sa lin e, less than 5% of t he radioactivity a dd ed was prec ipitated. That is, [' 25I ]epidermolysin remains soluble in 50 % saturated a mmon ium s ulfate unless it is bound to specific antiserum . This a llows distinct separation of free fro m a ntibod y-bo und ep id ermolysin in t he rad ioimmunoassay . Figure 4 illustrates the cha racteri zation of t he ra bbit a ntiserum selected for use in t he radioimmunoassay. Antigen-binding capacity, expressed as ABC-33, is calculated from t he reciprocal of the serum dilu tion which precipitates 33 % of t he ant igen added (in this case 2150, as indicated in Figure 4 ). The ABC-33 of t his a nt iserum was 27.7 Ilg a nti gen nitroge n per ml [9] . In the radioimmunoassay itself, a dilu t ion of antiserum (1:750) cap able of precipitating 60 % of the ant ige n added was used .
A stand a rd curve for com pa rison when measuring unknown amounts of epidermolysin was 
M easurem ent of [' 25l]Epidermolysin in Viu o
After injection of 20 Il g of [ ' 25 1 Jepidermolys in in t raperitoneall y in 6 I-day-old mi ce, blood was obtained at 30-min interva ls fr om the tail vein in 10-111 he pa rini zed mi crop ipets. The whole bl ood leve ls of epidermolysin up to t he time of generalized pee ling or death are s hown in Figure 6 . Four a nim a ls survived the experim ent a nd ex perienced genera li zed pos it ive Nikols ky ph enomena . Two a nimals di ed, poss ibl y due to excess ive blood loss , and did not develop epidermolysis.
Epidermolysin was a lso measured by direct gamma radi ation co un ting of wei ghed whole s kin o r peeled epidermis obtained at the t im e of genera li zed pee lin g in t he four surviving anima ls as s hown in Figure 7 . The concentration of e pid ermolys in in peeled ep idermis see ms to be in creased compared to the concentrat ion in whole s kin or blood at t he time of ge n era li zed peeling.
DISCUSS IO N
A systematic eva luat ion of t he fa cto rs t hat influence t he measu re m ent of t he sta phy lococca l epide rmol yt ic toxin by bioassay revea led that the age of mi ce used in t he assay has a critical influ ence on t he results obta in ed (Fig . 1) . The variabi li ty we expe rienced in d ay-to-day test in g of t he toxin was eliminated if mi ce of identi ca l age were empl oyed a nd if we used t he linea r porti on of the dose-res ponse curve . For t he functiona l assay, we recomm end t hat a uni t be estab lis hed whi ch falls within t he linea r portion of the curve. For example, we present ly d efine one unit as t hat quantity of epidermolysin in 0.02 ml whi ch will result in epidermal separati on 60 min after in t rautaneous injection in a I-day old m ouse. In our hands, this corresponds to a pproximately 500 n g of highly purified epidermolysin.
We prefer to inject a s m a ll volume, 20 Ill , s ince appreciable leakage of the injected fluid occurs wit h larger vol umes (such as 50 or 100 Ill). We a lso favor intracutaneous injections and testing for 
Hours ofler Injection
Wh ole Sk in EpidermIS Flc. 7. 1 ' 2 '1 JEpiderm olysin levels in blood, whole skin, and peeled epidermis of four newborn mice at the time of generalized peeling 3 to 4 hr post intrape ri toneal injection of 20 /Lg per mouse. The toxin seemed to be concentrated in peeled epidermis on a Il g per gm basis as compared to whole skin or blood .
peelin g in the skin overlyin g t he Injection sit e, beca use the time required for assay is short by this method and the assay has a crisp end point. The anima ls need not be returned to their mothers in such short-term experiments and this prevents loss due to cannib alis m.
The minimum detectible concentration of epidermolysin in the bioassay is 5 J. L g per ml (100 ng in 0.02 ml), although wi t h this dose peeling is us ua lly not ed 3 to 4 hr after injection and occ urs in the nonlinear port ion of the dose-response curve. T o our knowledge , the only func t ional assay of epidermolysin is t he bioassay.
1mmunoassays offer an adva nta ge of precision and reproducibility but do not measure fun ction . Radial immunodiffusion is readil y ada pted to prec ise measurement of the toxin . The sensitivity of this assay was similar to bioassay, sin ce t he minimum concent ration t hat could be measured accurately by thi s assay was a lso about 5 J. Lg per ml. Radia l immunodiffusion is useful for prepara tive studies a nd toxin purification , since it does not require t he use of labora tory anima ls. However, for measurement of tox in or a nt ibody to toxin in serum or body fluids in a clinica l settin g, a still more sensitive assay method , t he radioimmunoassay, was required. Bioassay or ra di a l immunodiffusion did not detect toxin in serum of children experiencin g the staphylococcal scalded-skin syndrome.
S in ce the tox in was soluble in ha lf-saturated a mmonium sulfate, a single anti body ra dioimmunoassay was readil y d eveloped usin g t he Fa rr technique [9 ] . Its sensitivity is as low as 20 ng per ml a nd its s peci fi city was esta blished by a ddi t ion of known qua nt it ies of cold epidermolysin to serum . Th e sta phylococcal produ cts a-tox in , entero toxin A, or enterotoxin B did not inhibit bindin g of [ 1 25 1 )epidermolysin to s pecifi c a ntibody in t he radioimmunoassay, nor did they form precipitin bands aga inst rabbit anti-epidermolysin by double immunodiffusion in agar (method of OuchterJ ony) .
Kondo and associat es have rece nt ly reported t he existence of two serotypes of epidermolysin [12, 13 ] . Phage group II S . aureus strains usually pro duce t he heat-sta bl e epid ermolysin ; non-phage group II organisms produce a less sta ble toxin whi ch is a nt ige nically distin ct . Some orga nisms produce both ty pes. The epidermolysin fr om t he S. aureus isolate we st udi ed was heat sta ble and gave a sin gle prec ipitin ba nd in Ouchterlony double immunodiffusion studi es [6 ] . Therefore, our ra dioimmunoassay may not detect t he less stable epidermolysin . Wiley a nd associates have reported t he d evelopm ent of a prim a ry binding assay for huma n a nt ibody to epiderm olys in [14 ) , but gave no data on measurement of epidermolysin itse lf.
We d etected radioactivity in t he blood , whole skin , and peeling epidermis 3 hr a fter in t ra peri tonea l injection of [ 3-fold in the epidermis as compa red to whole skin or blood . Although no conclusions about mechanism of action can be drawn from this study, it does suggest tha t epidermolysin binds preferentially t o a site or sites in t he epidermis. S . aureus-associated sca lded-skin syndrome is a dramatic but rarely fa tal form of epiderma l injury. Toxic epidermal necrol ysis of nonsta phylococcal origin, usually caused by drugs. is more often fatal a nd is difficult to distinguish clinically from th e S . aureus-assoc iat ed disease. The trea t ment of these two diseases differs, so early distinction between them is importa nt. We plan to use the ra dioimmunoassay to study this problem , and to study the oth er forms of the sta phylococca l sca lded -skin syndrome, staphylococcal scarlatiniform erupt ion and bullous impetigo.
